It's a nightmare the very sick can find themselves in: Communicating their health history from one doctor to the next to get the critical care they need. It's been an extra burden during this already difficult time. Now, a Silicon Valley tech entrepreneur is trying to change that by fulfilling an important promise.
Search
Recent Posts
See AllBy: Harrison Weber With venture capital pouring record amounts of money into Los Angeles tech, small startups are seeing a boon. Seed deals hit new highs in the first half of this year, topping $330 m
Key takeaways • Real-world evidence (RWE) has the potential to be useful across the entire healthcare ecosystem, including for clinical trials, care provision, determining treatment outcomes, and post
Invitae (NYSE: NVTA), a leading medical genetics company, today announced it has entered into a definitive agreement to acquire Ciitizen, a patient-centric consumer health tech company. Backed by a16z